Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
1 hedge funds and large institutions have $1K invested in Neurotrope, Inc. Common in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 33 closing their positions.
97% less funds holding
Funds holding: 34 → 1 (-33)
100% less capital invested
Capital invested by funds: $2.07M → $1K (-$2.07M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 33
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$378K |
| 2 |
Renaissance Technologies
New York
|
-$375K |
| 3 |
AFAS
Acorn Financial Advisory Services
Reston,
Virginia
|
-$279K |
| 4 |
PTP
Platform Technology Partners
New York
|
-$167K |
| 5 |
OGC
One68 Global Capital
New York
|
-$160K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CG
26
Cutler Group
San Francisco,
California
| – | -$2K | -2,200 | Closed |
|
|
CCM
27
Chiron Capital Management
Tallahassee,
Florida
| – | -$2K | -1,500 | Closed |
|
28
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$2K | -1,464 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -473 | Closed |
|
NTRP Hedge Fund Activity: Q4 2020 in Review
1 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q4 2020, worth a combined $1K — down 100% from $2.07M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of NTRP and 0 opened new positions — a net loss of 33 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $378K sold.
- 1 institutional investor held Neurotrope, Inc. Common (NTRP) as of Q4 2020, down from 34 in Q3 2020.
- Funds reported $1K of Neurotrope, Inc. Common stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new Neurotrope, Inc. Common positions in Q4 2020 and 33 closed out, a net change of -33 holders.
- The largest Neurotrope, Inc. Common seller in Q4 2020 was Vanguard Group, an estimated $378K sold.
Based on aggregated 13F filings for Q4 2020.